Schrödinger today announced that new preclinical data on SGR-3515 and SGR-4174 will be presented at the AACR Annual Meeting ...
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced two plixorafenib abstracts have been ...
Shadow Power, a leader in customer energy resource (CERs) management, proudly announces that its platform is now OpenADR 2.0b certified. This milestone reinforces Shadow Power's ability to transform ...
On this episode of Dinner SOS, Chris and Shilpa are here to help George tackle plant-based proteins. ON THIS WEEK’S episode ...